Randy H Thurman - Net Worth and Insider Trading
Randy H Thurman Net Worth
The estimated net worth of Randy H Thurman is at least $471,265 dollars as of 2024-04-26. Randy H Thurman is the Director of Veradigm Inc and owns about 58,905 shares of Veradigm Inc (MDRX) stock worth over $465,939. Randy H Thurman is the Director of Outlook Therapeutics Inc and owns about 594 shares of Outlook Therapeutics Inc (OTLK) stock worth over $5,007. Randy H Thurman is also the Executive Chairman of Presbia PLC and owns about 21,229 shares of Presbia PLC (LENSF) stock worth over $318. Besides these, Randy H Thurman also holds Arno Therapeutics Inc (ARNI) , TFF Pharmaceuticals Inc (TFFP) . Details can be seen in Randy H Thurman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randy H Thurman has not made any transactions after 2022-09-29 and currently still holds the listed stock(s).
Transaction Summary of Randy H Thurman
Randy H Thurman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randy H Thurman owns 6 companies in total, including Outlook Therapeutics Inc (OTLK) , TFF Pharmaceuticals Inc (TFFP) , and Veradigm Inc (MDRX) among others .
Click here to see the complete history of Randy H Thurman’s form 4 insider trades.
Insider Ownership Summary of Randy H Thurman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OTLK | Outlook Therapeutics Inc | 2020-09-14 | director |
TFFP | TFF Pharmaceuticals Inc | 2022-09-29 | director |
MDRX | Veradigm Inc | 2014-11-11 | director |
LENSF | Presbia PLC | 2017-03-13 | director & Executive Chairman |
ARNI | Arno Therapeutics Inc | 2014-01-24 | director |
OFIX | Orthofix Medical Inc | 2013-11-05 | director |
Randy H Thurman Latest Holdings Summary
Randy H Thurman currently owns a total of 5 stocks. Among these stocks, Randy H Thurman owns 58,905 shares of Veradigm Inc (MDRX) as of November 11, 2014, with a value of $465,939 and a weighting of 98.87%. Randy H Thurman owns 594 shares of Outlook Therapeutics Inc (OTLK) as of September 14, 2020, with a value of $5,007 and a weighting of 1.06%. Randy H Thurman also owns 21,229 shares of Presbia PLC (LENSF) as of November 25, 2015, with a value of $318 and a weighting of 0.07%. The other 2 stocks Arno Therapeutics Inc (ARNI) , TFF Pharmaceuticals Inc (TFFP) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Randy H Thurman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MDRX | Veradigm Inc | 2014-11-11 | 58,905 | 7.91 | 465,939 |
OTLK | Outlook Therapeutics Inc | 2020-09-14 | 594 | 8.43 | 5,007 |
LENSF | Presbia PLC | 2015-11-25 | 21,229 | 0.02 | 318 |
ARNI | Arno Therapeutics Inc | 2013-05-22 | 1,250 | 0.00 | 0 |
TFFP | TFF Pharmaceuticals Inc | 2022-09-29 | 0 | 2.92 | 0 |
Holding Weightings of Randy H Thurman
Randy H Thurman Form 4 Trading Tracker
According to the SEC Form 4 filings, Randy H Thurman has made a total of 0 transactions in Veradigm Inc (MDRX) over the past 5 years. The most-recent trade in Veradigm Inc is the acquisition of 8,849 shares on November 11, 2014, which cost Randy H Thurman around $99,905.
According to the SEC Form 4 filings, Randy H Thurman has made a total of 1 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 500 shares on September 14, 2020, which cost Randy H Thurman around $6,200.
According to the SEC Form 4 filings, Randy H Thurman has made a total of 0 transactions in Presbia PLC (LENSF) over the past 5 years. The most-recent trade in Presbia PLC is the acquisition of 1,833 shares on November 25, 2015, which cost Randy H Thurman around $9,990.
More details on Randy H Thurman's insider transactions can be found in the Insider Trading History of Randy H Thurman table.Insider Trading History of Randy H Thurman
- 1
Randy H Thurman Trading Performance
GuruFocus tracks the stock performance after each of Randy H Thurman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randy H Thurman is 6.45%. GuruFocus also compares Randy H Thurman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randy H Thurman within 3 months outperforms 4 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randy H Thurman's insider trading performs compared to the benchmark.
Performance of Randy H Thurman
Average Return
35.15%
Outperforming Transactions
44%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 5.14 | 6.45 | 13.25 | 35.15 | -21.28 | -26.69 |
Relative Return to S&P 500(%) | 3.53 | 2.44 | 5.99 | 22.57 | -32.89 | -37.21 |
Randy H Thurman Ownership Network
Ownership Network List of Randy H Thurman
Ownership Network Relation of Randy H Thurman
Randy H Thurman Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Randy H Thurman is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Randy H Thurman made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 368,671 shares made by Jeff Evanson , a net sale of 520,000 shares made by Terry Dagnon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,006 shares, with a net purchase of 5,006 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 42,552 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Randy H Thurman Mailing Address
Above is the net worth, insider trading, and ownership report for Randy H Thurman. You might contact Randy H Thurman via mailing address: 222 Merchandise Mart Plaza, Suite 2024, Chicago Il 60654.